Foster Dykema Cabot & Co’s QuidelOrtho QDEL Stock Holding History

Foster Dykema Cabot & Co’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-65	Closed	-$5K	–	378
2023 Q2	$5K	Buy	+65	New	+$5.69K	﹤0.01%	306

Other funds holding QDEL

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Foster Dykema Cabot & Co's QDEL Position: Q3 2023 in Review

Foster Dykema Cabot & Co sold out of QuidelOrtho (QDEL) in Q3 2023, closing a stake of 65 shares — an estimated $5K sold.

Foster Dykema Cabot & Co first reported a position in QDEL in Q2 2023 and held it in 1 quarter. The position peaked at $5K in Q2 2023. 303 funds tracked by Wall St. Rank hold QDEL as of Q3 2023.

Foster Dykema Cabot & Co reported no remaining QuidelOrtho position as of Q3 2023 after selling out during the quarter.
Foster Dykema Cabot & Co sold 65 QuidelOrtho shares in Q3 2023, an estimated $5K.
Foster Dykema Cabot & Co first reported a position in QuidelOrtho in Q2 2023 and held it in 1 quarter.
Foster Dykema Cabot & Co's QuidelOrtho position peaked at $5K in Q2 2023.
303 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.